Eisai has joined the Tuberculosis Drug Accelerator (TBDA) partnership, a new initiative that aims to speed the discovery of essential new treatments for tuberculosis (TB). The TBDA partnership, launched in June 2012 through a collaboration between several pharmaceutical companies, research institutions and with support from the Bill & Melinda Gates Foundation, targets the discovery of new TB drugs by working together on early-stage research. The long-term goal of the partnership is to create...